Clinical Trials Directory

Trials / Unknown

UnknownNCT06250569

Adenomyosis in Fertile Women in MUSA Criteria

Application of the Revised Morphological Uterus Sonographic Assessment (MUSA) Criteria to Diagnose Adenomyosis in Fertile Women

Status
Unknown
Phase
Study type
Observational
Enrollment
144 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
Female
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

1. To estimate the prevalence of adenomyosis in fertile women aged 18-30 years using the revised MUSA ultrasound criteria. 2. To evaluate clinical risk factors that are associated with adenomyosis diagnosis in this population

Detailed description

Adenomyosis is a benign condition characterized by the presence endometrial glands and stroma within the myometrium. Its prevalence varies from 5-70%. The definitive diagnosis of adenomyosis is based mainly on histological assessment of hysterectomy specimens. This led to a concept that adenomyosis affects only parous women between 35-50 years who complain of dysmenorrhea and heavy menstrual bleeding. Magnetic Resonance Imaging (MRI) can detect adenomyosis with a sensitivity of 80%. Transvaginal ultrasound using the revised Morphological Uterus Sonographic Assessment (MUSA) criteria can detect adenomyosis non-invasively at a lower cost. Such advancements in imaging techniques allow studying the prevalence of the disease in wider range of population including young women.

Conditions

Timeline

Start date
2024-02-01
Primary completion
2025-06-01
Completion
2025-07-01
First posted
2024-02-09
Last updated
2024-02-09

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06250569. Inclusion in this directory is not an endorsement.

Adenomyosis in Fertile Women in MUSA Criteria (NCT06250569) · Clinical Trials Directory